STOCK TITAN

Eloxx Pharmaceuticals (ELOX) Net Income by Year

ELOX NASDAQ

Eloxx Pharmaceuticals, Inc. reported a net loss of $6.0M in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Eloxx Pharmaceuticals, Inc. has filed alongside them.

FY2025 annual
Net Income -$6.0M
YoY n/m
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ELOX Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25S-1FY24S-1FY23S-1FY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Net Income-$6.0Mn/m-$3.1MN/A-$36.1Mn/m-$66.7Mn/m-$34.6Mn/m-$50.9Mn/m-$47.2Mn/m-$21.2Mn/m-$9.8Mn/m-$6.4Mn/m-$9.2Mn/m-$6.1Mn/m-$5.1Mn/m-$7.3M

ELOX Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'26S-1Q1'26S-1Q4'26S-1Q4'25S-1Q3'25S-1Q2'25S-1Q2'24S-1Q3'2410-QQ2'2310-QQ1'2310-QQ4'2310-QQ3'2310-Q
Net Income-$4.5M-$3.8MN/A-$1.9M-$1.7Mn/mN/AN/A-$3.6Mn/m-$4.3Mn/m-$6.2Mn/mN/A-$7.5Mn/m

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Eloxx Pharmaceuticals, Inc. financials

Frequently Asked Questions

What was Eloxx Pharmaceuticals, Inc.'s net income in fiscal year 2025?

Eloxx Pharmaceuticals, Inc. reported a net loss of $6.0M in fiscal year 2025.

How fast is Eloxx Pharmaceuticals, Inc.'s net income growing?

Eloxx Pharmaceuticals, Inc. (ELOX) reported a $3.1M net loss in fiscal year 2024 and a $6.0M net loss in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.

How has Eloxx Pharmaceuticals, Inc.'s net income changed over the years?

Across the 15 fiscal years this page covers, Eloxx Pharmaceuticals, Inc. (ELOX) net income went from -$7.3M in fiscal year 2011 to -$6.0M in fiscal year 2025.

Eloxx Pharmaceuticals, Inc. (ELOX) reported -$4.5M in net income in Q2 2026.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Eloxx Pharmaceuticals, Inc. (ELOX) reported on that line in every period on record.